Search Results - "Almquist, Daniel"

The Role of Immune Checkpoint Inhibitors in Colorectal Adenocarcinoma by Almquist, Daniel R., Ahn, Daniel H., Bekaii-Saab, Tanios S.

“…Over the past decade, immune checkpoint inhibitors (ICI) have proven to be promising agents in a number of solid tumor malignancies. Pembrolizumab and…”
Get full text

Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations by DeLeon, Thomas T, Almquist, Daniel R, Kipp, Benjamin R, Langlais, Blake T, Mangold, Aaron, Winters, Jennifer L, Kosiorek, Heidi E, Joseph, Richard W, Dronca, Roxana S, Block, Matthew S, McWilliams, Robert R, Kottschade, Lisa A, Rumilla, Kandelaria M, Voss, Jesse S, Seetharam, Mahesh, Sekulic, Aleksandar, Markovic, Svetomir N, Bryce, Alan H

“…CDKN2A and TP53 mutations are recurrent events in melanoma, occurring in 13.3% and 15.1% of cases respectively and are associated with poorer outcomes. It is…”
Get full text

Clinical Characteristics of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Retrospective Analysis by Almquist, Daniel R, Sonbol, Mohamad Bassam, Ross, Helen J, Kosiorek, Heidi, Jaroszewski, Dawn, Halfdanarson, Thorvardur

Get full text

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: DIPNECH by Almquist, Daniel R., Ernani, Vinicius, Sonbol, Mohamad Bassam

“…Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare premalignant condition. Over the past decade, there has been increased…”
Get full text

Systemic Therapy and Sequencing Options in Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysis by Sonbol, Mohamad Bassam, Riaz, Irbaz Bin, Naqvi, Syed Arsalan Ahmed, Almquist, Daniel R, Mina, Syeda, Almasri, Jehad, Shah, Shiv, Almader-Douglas, Diana, Uson Junior, Pedro Luiz Serrano, Mahipal, Amit, Ma, Wen Wee, Jin, Zhaohui, Mody, Kabir, Starr, Jason, Borad, Mitesh J, Ahn, Daniel H, Murad, M Hassan, Bekaii-Saab, Tanios

“…The treatment landscape for advanced hepatocellular carcinoma (HCC) has recently changed and become relatively confusing. Head-to-head comparisons between most…”
Get more information

The not so small role of adjuvant chemotherapy in resected non-small cell lung cancer by R. Almquist1, Daniel, Savvides1, Panayiotis, Ernani1, Vinicius

Get full text

Initial management of immune thrombocytopaenia in adults based on risk stratification by Umakanthan, Jaydev Manikkam, Dhakal, Prajwal, Gundabolu, Krishna, Kallam, Avyakta, Almquist, Daniel R, Bhatt, Vijaya Raj

“…Patients with immune thrombocytopaenia (ITP) have a wide spectrum of disease severity and bleeding risk even at similar platelet counts. Hence, additional…”
Get full text

Abstract OT2-04-06: A phase I study of pembrolizumab combined with ruxolitinib in triple negative breast cancer (TNBC) by Almquist, Daniel

“…Background: Recent data from the Impassion130 trial has shown the clinical benefit of PD-1/PD-L1 checkpoint blockade immunotherapy, in combination with…”
Get full text

Outcomes of COVID-19 in Patients With Cancer: A Closer Look at Pre-Emptive Routine Screening Strategies by Xie, Zhuoer, Saliba, Antoine N, Abeykoon, Jithma, Majeed, Umair, Almquist, Daniel R, Wiedmeier-Nutor, Julia E, Bezerra, Evandro, Andrade-Gonzalez, Xavier, Hickman, Ashley, Sorenson, Karl, Rakshit, Sagar, Wee, Christopher, Tella, Sri Harsha, Kommalapati, Anuhya, Abdallah, Nadine, Pritchett, Joshua, De Andrade, Mariza, Uprety, Dipesh, Badley, Andrew, Manochakian, Rami, Ailawadhi, Sikander, Bryce, Alan H, Hubbard, Joleen M, Gangat, Naseema, Thompson, Carrie A, Witzig, Thomas E, McWilliams, Robert R, Leventakos, Konstantinos, Halfdanarson, Thorvardur R

“…The benefit of routine pre-emptive screening for severe acute respiratory syndrome coronavirus 2 infections in patients with cancer before cancer-directed…”
Get more information

The Road Less Traveled: A Guide to Metastatic ROS1 -Rearranged Non-Small-Cell Lung Cancer by Almquist, Daniel, Ernani, Vinicius

“…Over the past decade, significant advances have been achieved in the diagnostic testing, treatment, and prognosis of advanced non-small-cell lung cancer…”
Get more information

Proton Pump Inhibitors Associated with Higher Incidence of Mucositis in Patients Receiving Methotrexate for Graft Vs Host Disease Prophylaxis by Mountjoy, Luke, Almquist, Daniel, Ofori, Henry, Girardo, Marlene, McCallen, Margaret

“…Introduction- Graft-versus-host disease (GVHD) is a major complicating factor in determining morbidity and mortality following allogeneic stem cell transplant…”
Get full text

Preoperative Pulmonary Function Tests (PFTs) and Outcomes from Resected Early Stage Non-small Cell Lung Cancer (NSCLC) by Almquist, Daniel, Khanal, Nabin, Smith, Lynette, Ganti, Apar Kishor

“…Preoperative pulmonary function tests (PFTs) predict operative morbidity and mortality after resection in lung cancer. However, the impact of preoperative PFTs…”
Get full text

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: DIPNECH by Almquist, Daniel R., Ernani, Vinicius, Sonbol, Mohamad Bassam

Get full text

Chemoimmunotherapy in patients with extensive-stage small cell lung cancer and a poor performance status by Agarwal, Muskan, Liu, Alex, Almquist, Daniel, Langlais, Blake T, Leventakos, Konstantinos, Yu, Nathan Y, Manochakian, Rami, Ernani, Vinicius

“…Immune checkpoint inhibitor combined with platinum-etoposide is the standard first-line therapy for patients with extensive-stage small cell lung cancer…”
Get full text

Clinical Characteristics of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia by Almquist, Daniel R., Sonbol, Mohamad Bassam, Ross, Helen J., Kosiorek, Heidi, Jaroszewski, Dawn, Halfdanarson, Thorvardur

Get full text

Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell Hyperplasia by Al-Toubah, Taymeyah, Strosberg, Jonathan, Halfdanarson, Thorvardur R., Oleinikov, Kira, Gross, David J., Haider, Mintallah, Sonbol, Mohamad Bassam, Almquist, Daniel, Grozinsky-Glasberg, Simona

“…Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare lung disease associated with proliferation of neuroendocrine cells in the lung…”
Get full text

Treatment landscape of advanced high-grade neuroendocrine neoplasms by Alheraki, Samee Zane, Almquist, Daniel R, Starr, Jason S, Halfdanarson, Thorvardur R, Sonbol, Mohamad Bassam

“…Grade 3 neuroendocrine neoplasms (NEN G3) are high-grade (Ki-67 index >20%) neuroendocrine malignancies that comprise both rapidly proliferating,…”
Get full text

Chemoimmunotherapy for the treatment of extensive-stage small cell lung cancer (ES-SCLC) in patients with an Eastern Cooperative Group (ECOG) performance status (PS) of two or greater by Almquist, Daniel, Langlais, Blake, Yu, Nathan Y, Sio, Terence Tai Weng, Savvides, Panos, Yang, Ping, Schild, Steven E., Mansfield, Aaron Scott, Ernani, Vinicius

“…Abstract only 8569 Background: Immune checkpoint inhibitor (atezolizumab or durvalumab) combined with platinum-etoposide is the standard first-line therapy for…”
Get full text

Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3 by Agarwal, Muskan, Liu, Alex, Langlais, Blake T., Leventakos, Konstantinos, Yu, Nathan Y., Almquist, Daniel, Manochakian, Rami, Ernani, Vinicius

“…Studies demonstrated that chemoimmunotherapy prolongs progression-free survival (PFS) and overall survival (OS) in patients with extensive-stage small-cell…”
Get full text

Initial Management of Immune Thrombocytopenia in Adults Based on Risk Stratification by Umakanthan, Jayadev Manikkam, Dhakal, Prajwal, Gundabolu, Krishna, Kallam, Avyakta, Almquist, Daniel R., Bhatt, Vijaya R

“…Patients with immune thrombocytopenia (ITP) have wide spectrum of disease severity, and bleeding risk even at similar platelet counts. Hence, additional…”
Get full text